Our lab is interested in understanding the molecular processes that underlie the genesis & progression of human tumors. #NarlaLab @umichmedicine @UMRogelCancer
"So proud of our research team for identifying a new therapeutic approach to treating TKI resistant leukemias. A special thanks to the @UMRogelCancer for supporting the work." - Dr. @gouthamnarla
https://t.co/AnpmTmDHzm
So proud of our collaboration with Professor Odero and Dr. Vicente on the role of PP2A in regulating response to targeted therapies in AML @NarlaLabUMich@UMRogelCancer and so excited that Irene will be joining our group as a postdoctoral fellow next year
We are grateful to once again be named the #1 Cancer Program in Michigan by @usnews. The dedication from our staff, nurses and physicians continue to keep us the best in Michigan and one of the top programs in the nation. Read more about the rankings: https://t.co/k02G0I3oZu
Today at 4PM graduate student, Alexis Harold, will be presenting her research project titled "Exploring How Activation of PP2A Regulates Estrogen Receptor in ER+ Breast Cancer" at the UM Cancer Biology seminar. Link: https://t.co/gkaJn1JvOj Meeting ID: 98434180868 Passcode: CB800
Congratulations to all 2022 recipients including Rogel Scholars Drs. @gouthamnarla, Vaibhav Sahai & Ryan Wilcox and Clinical Research Early Investigator Dr. @mpianko!
Great to see such interest in Rita Avelar’s work on PP2A modulators and PARPi for the treatment of high grade serous cancer. #AACR22#teamwork@NarlaLabUMich @CDMRP funded
The @AACR Annual Meeting 2022 features presentations and posters from many #RogelCancer researchers. Take a look at today's lineup!
https://t.co/cQibuG3lmj